Braunwald’s heart disease family of books
SECTION I. Interventional Cardiology
1. The birth of interventional cardiology
The innovator of angioplasty
The first peripheral arterial angioplasty
The development of coronary angioplasty
Coronary angioplasty then and now
Acute angioplasty failure
Mechanism of balloon angioplasty
Dissemination of coronary angioplasty
Andreas Grüntzig, the man
Development of interventional cardiology and minimally invasive surgery
2. Guidelines and appropriateness criteria for interventional cardiology
Other methods to improve quality
Putting guidelines into practice
3. Vascular access and closure
Femoral arterial access site closure
Radial arterial access and closure
Ulnar arterial access and closure
Distal radial arterial access and closure
Brachial arterial access and closure
Venous access and closure
4. Pharmacotherapy in the modern interventional suite
Pathophysiology of arterial thrombosis
Oral P2Y12 receptor inhibitors
Intravenous antiplatelet drugs
Intravenous anticoagulant drugs
Vasodilators and antihypertensive drugs
Vasopressors and inotropic drugs
Procedural sedation: Anxiolytics and analgesics
5. Hemodynamic support during high-risk percutaneous coronary intervention
Rationale for definition of “high risk”
Coronary blood flow and myocardial energetics during high-risk percutaneous coronary intervention
Extracorporeal membrane oxygenation
History of development of left ventricular support devices for high-risk percutaneous coronary intervention
History of use of intraaortic balloon pump during high-risk percutaneous coronary intervention
Balloon-pump assisted coronary intervention study
History of tandemheart development
Transvalvular axial flow pumps
History of impella development
Clinical trials of impella in high-risk percutaneous coronary intervention
Optimal use of impella for hemodynamic support
Conclusion: Future advances
6. Radiation safety in the cardiac catheterization laboratory
Operation of X-ray fluoroscopic equipment
Fluoroscopic image quality
Assessment of radiation dose
Radiation reduction in the catheterization laboratory
Occupational hazards of the catheterization laboratory
The catheterization laboratory of the future
Properties of contrast media
Adverse effects related to contrast media administration
Contrast-associated acute kidney injury
SECTION II. Coronary Artery Intervention
8. Percutaneous coronary intervention for unprotected left main coronary artery disease
Randomized controlled trials
Current guidelines and appropriate use criteria
Disease location: Ostial or midshaft versus distal left main coronary artery
One- versus two-stent approach for left main coronary artery bifurcation disease
Dedicated bifurcation stents
Importance of final proximal optimization technique and selective kissing balloon inflation
Myocardial infarction caused by left main coronary artery thrombosis
Dual antiplatelet therapy selection and duration
Follow-up after left main coronary artery percutaneous coronary intervention
Left main coronary artery bifurcation PCI techniques
Provisional stent technique
Description of techniques
Ostial left main coronary artery percutaneous coronary intervention
9. Chronic total coronary occlusions: Rationale, techniques, and clinical outcomes
Simplified guidelines after 20 years of bifurcation studies
An individualized approach to bifurcations
Technical aspects of bifurcation percutaneous coronary intervention
11. Bypass graft interventions
Indications for bypass graft interventions
Distal embolization and embolic protection devices
Saphenous vein graft stenting
Adjunctive pharmacotherapy
Technical aspects of saphenous vein graft percutaneous coronary intervention: Intravascular imaging
Saphenous vein graft engagement
Acutely occluded saphenous vein grafts
Chronically occluded saphenous vein grafts
Intermediate saphenous vein graft lesions
Saphenous vein graft percutaneous coronary intervention complications
Arterial graft interventions
Complications of percutaneous coronary intervention in prior coronary artery bypass grafting patients
Scoring balloon angioplasty
Excimer laser atherectomy
Intracoronary lithotripsy
13. Treatment of in-stent restenosis
Cutting and scoring balloons
Future interventional paradigms
14. Management of thrombotic lesions
Pharmacologic strategies to prevent thrombus formation
Thrombus in various clinical scenarios
Devices to remove thrombus
Devices that are not beneficial
15. Fractional flow reserve and nonhyperemic pressure ratios
Rationale for translesional physiologic measurements
Derivation of fractional flow reserve and nonhyperemic pressure indices
Role of submaximal coronary hyperemia with contrast fractional flow reserve
Nonhyperemic pressure ratios
Coronary flow reserve versus fractional flow reserve
Fractional flow reserve and myocardial bed size
Technique of intracoronary pressure measurement
Pharmacologic coronary hyperemia
Validation of fractional flow reserve and nonhyperemic pressure ratio
Discordance between nonhyperemic pressure ratio and hyperemic indices
Fractional flow reserve/nonhyperemic pressure ratio for specific angiographic subsets
Multivessel disease percutaneous coronary intervention
Nonhyperemic pressure ratio and intermediate lesion assessment
Serial (multiple) lesions and diffuse coronary artery disease
Fractional flow reserve in acute coronary syndrome
Post-percutaneous coronary intervention physiology
Assessing collateral flow
Index of microcirculatory resistance
Summary and future directions
The future of intracoronary physiology: Angiographically derived fractional flow reserve
16. Intravascular ultrasound imaging
Background and limitations of angiography
Intravascular ultrasound imaging: Basic image and measurements
Guidelines for use and appropriate indications
Interventional applications
Intravascular ultrasound imaging in the peripheral arterial system
Research applications: Progression and regression trials
Advancing intravascular ultrasound technologies and future directions
17. Optical coherence tomography
Physics of optical coherence tomography
Image acquisition by frequency domain optical coherence tomography
Evaluation of coronary pathology
Pitfalls of image interpretation
Assessment of coronary plaque characteristics
Role of optical coherence tomography in percutaneous coronary intervention
SECTION III. Peripheral Artery Intervention
18. Intervention for lower extremity arterial disease
Percutaneous revascularization tools
Controversy over paclitaxel-coated balloons and stents
Interventions in specific arteries
19. Upper extremity intervention
Diagnosis and clinical syndromes
20. Renal artery intervention: Catheter-based therapy for renal artery stenosis
Renal artery intervention
Asymptomatic renal artery stenosis
Renovascular hypertension
Cardiac destabilization syndromes
21. Mesenteric artery interventio n: Catheter-based therapy for chronic mesenteric ischemia
Management of chronic mesenteric ischemia
Role of the kidneys in hypertension
Anatomy and physiology of the renal sympathetic nervous system
Animal and human data supporting a link between the renal sympathetic nervous system and hypertension
Percutaneous renal sympathetic denervation: Early trials using a single electrode radiofrequency catheter
Limitations of early trials
Practical aspects: Patient selection and performance of the procedure
Currently commercially available catheters
The peregrine system (see Figures 22.8 and 22.9)
Effect of renal denervation on conditions of sympathetic overactivity other than hypertension
Sympathetic nerve activity mapping and tailored ablation
23. Endovascular management of aortic and thoracic aneurysms
Abdominal aortic aneurysm
Thoracic endovascular aortic repair
SECTION IV. Cerebrovascular Intervention
24. Carotid and vertebral intervention
25. Cerebrovascular interventions
Acute ischemic stroke treatment
SECTION V. Venous Intervention
26. Interventional management of lower extremity deep vein thrombosis and pulmonary embolism
Lower extremity deep vein thrombosis
Acute deep vein thrombosis
Chronic deep vein thrombosis
Epidemiology and classification
Treatment escalation for massive pulmonary embolism
Treatment escalation for submassive pulmonary embolism
27. Management of chronic venous insufficiency
Epidemiology and risk factors of chronic venous disease
Venous anatomy and physiology
Etiology and pathophysiology of chronic venous insufficiency
Evaluation and classification of patients with chronic venous insufficiency
Anatomic and physiologic testing of chronic venous insufficiency
Treatment of superficial chronic venous insufficiency
Endovascular management of venous ulcerations
28. Hemodialysis access intervention
Epidemiology and prevalence of stage V kidney disease
Pathogenesis of access failure
Catheter-based treatment of failing accesses
SECTION VI. Structural Heart Intervention
29. Aortic valvuloplasty and transcatheter aortic valve replacement
Balloon aortic valvuloplasty
Transcatheter aortic valve replacement (implantation): General concepts
Balloon-expandable valves
Complications of transcatheter aortic valve replacement
New transcatheter aortic valve replacement devices
30. Transcatheter mitral valve intervention
Introduction: Normal mitral valve anatomy
Mitral valve disease states
31. Transcatheter tricuspid valve intervention
Tricuspid valve regurgitation
Transcatheter tricuspid valve intervention devices
Leaflet-based repair technology
Tricuspid valve replacement
32. Hypertrophic cardiomyopathy
Introduction and epidemiology
Hallmarks and differential diagnosis
Natural course of disease and clinical presentation
Management of hypertrophic cardiomyopathy
Novel techniques for septal reduction using nonalcohol substances
Hypertrophic cardiomyopathy centers
33. Patent foramen ovale, atrial septal defect, left atrial appendage, and ventricular septal defect closure
Atrial septal defect closure
Left atrial appendage closure
Ventricular septal defect
Post-myocardial infarction ventricular septal defect
34. Interventions for advanced heart failure
Defining advanced heart failure
Hemodynamics of heart failure
Percutaneous mechanical circulatory support
Circulatory support for cardiogenic shock and advanced heart failure
Interventional therapy for right heart failure
Percutaneous coronary intervention in patients with heart failure
Valvular interventions in advanced heart failure
Emerging interventional approaches for heart failure
35. Endomyocardial biopsy
Development of the procedure: Historical perspective
Technique of the procedure
Safety of endomyocardial biopsy
Processing endomyocardial tissue specimens
Indications for endomyocardial biopsy
Endomyocardial biopsy in cardiac transplant allografts
36. Pericardiocentesis and pericardial intervention
Pericardial effusion and tamponade
Clinical diagnosis of pericardial tamponade
Indications for pericardiocentesis
Pericardiocentesis technique
Postpericardiocentesis catheter management
Complications of pericardiocentesis
Malignant, recurrent, or persistently draining pericardial effusions
Technique of single-balloon percutaneous balloon pericardiotomy
Technique of double-balloon percutaneous balloon pericardiotomy
Outcomes after percutaneous balloon pericardiotomy
Percutaneous pericardial biopsy
Technique of percutaneous pericardial biopsy
Percutaneous epicardial access for electrophysiology studies and ablation
Technique of pericardial access and epicardial mapping and ablation
Limitations and potential complications of pericardial access and epicardial ablation
Percutaneous pericardial access for transcatheter left atrial appendage ligation
Preprocedural considerations
Technique of percutaneous transpericardial left atrial appendage exclusion
SECTION VII. Congenital Heart Disease
37. Adult congenital heart disease: Cardiovascular interventions for pulmonary arterial hypertension, anomalous vascular connections, aortic coarctation, and pulmonary valve replacement
Adult congenital heart disease
Adults with congenital heart disease: Catheter interventions